SIOC 中文
CJOG
Adv search

Chinese Journal of Organic Chemistry >

2014 , Vol. 34 >Issue 8: 1573 - 1581

DOI: https://doi.org/10.6023/cjoc201402004

Articles

Synthesis, Crystal Structure, Antitumor Activity of Spiro-heterocyclic Mono-carbonyl Analogues of Curcumin

  • Wu Jianzhang ,
  • Weng Bixia ,
  • Qiu Peihong ,
  • Cai Zhijian ,
  • Fan Lei ,
  • Ying Shilong ,
  • Zhang Xiuhua ,
  • Wu Xiaoping ,
  • Liang Guang
Expand
  • a Chemical Biology Research Center, College of Pharmaceutical Sciences, Wenzhou Medical Universtiy, Wenzhou 325035;
    b Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000;
    b Institute of Tissue Transplantation and Immunology, Jinan University, Guangzhou 510632

Received date: 2014-02-05

  Revised date: 2014-04-05

  Online published: 2014-05-05

Supported by

Project supported by the National Natural Science Fundation of China (Nos. 81272462, 81102310), the Natural Science Fundation of Zhejiang Province (Nos. LY12H30004, Y4090379), the Technology Foundation for Medical Science of Zhejiang Province (No. 2012KYA129), the Project of Wenzhou Sci-Tech Bureau (No. S20100045), the Zhejiang Provicial Project of Key Scientific Group (No. 2010R50042-04).

Fold

Abstract

To discover novel lead compounds with good antitumor activity and low toxicity, 14 spiroheterocycle mono-car- bonyl analogs of curcumin (MCACs) were synthesized by 1,3-dipolar cycloaddition reaction. The one-pot reaction was carried out without catalyst, which showed the advantage of environmentally friendly. The structures of all compounds were characterized by ESI-MS, ESI-HRMS and 1H NMR. The crystal structure of B6 was confirmed as monoclinic system by X-ray diffraction, which indicated high region-selectivity and stereo-selectivity in the reaction of these compounds. All compounds were screened for their abilities to inhibit the growth of human gastric cell SGC-7901, glioma cell U251, human large cell lung cancer cell lines NCI-H460 by thiazolyl blue tetrazolium bromide (MTT) assay, and some of them showed good antitumor activity. Among the active compounds, B1, B6, B7 and B11 exhibited strong antitumor efficacy on the three tumor cells and low cytotoxicity against human liver cells HL-7702. Both compounds B1 and B7 can significantly induce the activation of apoptosis related proteins cysteinyl aspartate specific proteinase (caspase3) and poly ADP-ribose polymerase (PARP), and induce the apoptosis of tumor cell. The synthesized spiro heterocycles derived from MCACs in this study were novel antitumor compounds, and these compounds appeared to possess good research prospect in the area of anti-tumor drugs.

Key words： mono-carbonyl analogs of curcumin; spiro-heterocyclic; antitumor; synthesis

Cite this article

Wu Jianzhang , Weng Bixia , Qiu Peihong , Cai Zhijian , Fan Lei , Ying Shilong , Zhang Xiuhua , Wu Xiaoping , Liang Guang . Synthesis, Crystal Structure, Antitumor Activity of Spiro-heterocyclic Mono-carbonyl Analogues of Curcumin[J]. Chinese Journal of Organic Chemistry, 2014 , 34(8) : 1573 -1581 . DOI: 10.6023/cjoc201402004

References

[1] Bar-Sela, G.; Epelbaum, R.; Schaffer, M. Curr. Med. Chem. 2010, 17, 190.
[2] Zhao, C.; Liu, Z.; Liang, G. Curr. Pharm. Design 2013, 19, 2114.
[3] Agrawal, D. K.; Mishra, P. K. Med. Res. Rev. 2010, 30, 818.
[4] Wu, J.; Wang, C.; Cai, Y.; Yang, S.; Zheng, X.; Qiu, P.; Peng, J.; Wu, X.; Liang, G.; Li, X. Chin. J. Org. Chem. 2010, 30, 884 (in Chinese).
(吴建章, 王聪, 蔡跃飘, 杨树林, 郑晓咏, 仇佩虹, 彭景, 吴晓萍, 梁广, 李校堃, 有机化学, 2010, 30, 884.)
[5] Wu, J.; Li, J.; Cai, Y.; Pan, Y.; Ye, F.; Zhang, Y.; Zhao, Y.; Yang, S.; Li, X.; Liang, G. J. Med. Chem. 2011, 54, 8110.
[6] Wang, Y.; Xiao, J.; Zhou, H.; Yang, S.; Wu, X.; Jiang, C.; Zhao, Y.; Liang, D.; Li, X.; Liang, G. J. Med. Chem. 2011, 54, 3768.
[7] Xiao, J.; Wang, Y.; Peng, J.; Guo, L.; Hu, J.; Cao, M.; Zhang, X.; Zhang, H.; Wang, Z.; Li, X.; Yang, S.; Yang, H.; Liang, G. Int. J. Cancer 2012, 131, 1455.
[8] Selvendiran, K.; Tong, L.; Vishwanath, S.; Bratasz, A.; Trigg, N. J.; Kutala, V. K.; Hideg, K.; Kuppusamy, P. J. Biol. Chem. 2007, 282, 28609.
[9] Wilken, R.; Veena, M. S.; Wang, M. B.; Srivatsan, E. S. Mol. Cancer 2011, 10, 12.
[10] Subramaniam, D.; May, R.; Sureban, S. M.; Lee, K. B.; George, R.; Kuppusamy, P.; Ramanujam, R. P.; Hideg, K.; Dieckgraefe, B. K.; Houchen, C. W.; Anant, S. Cancer Res. 2008, 68, 1962.
[11] Brown, A.; Shi, Q.; Moore, T. W.; Yoon, Y.; Prussia, A.; Maddox, C.; Liotta, D. C.; Shim, H.; Snyder, J. P. J. Med. Chem. 2013, 56, 3456.
[12] Zhang, J.; Yang, P. L.; Gray, N. S. Nat. Rev. Cancer 2009, 9, 28.
[13] Liang, G.; Liu, Z.; Wu, J.; Cai, Y.; Li, X. Trends Pharmacol. Sci. 2012, 33, 531.
[14] Dandia, A.; Jain, A. K.; Laxkar, A. K. RSC Adv. 2013, 3, 8423.
[15] George, R. F.; Ismail, N. S.; Stawinski, J.; Girgis, A. S. Eur. J. Med. Chem. 2013, 68, 341.
[16] Maheswari, S. U.; Balamurugan, K.; Perumal, S.; Yogeeswari, P.; Sriram, D. Bioorg. Med. Chem. Lett. 2010, 20, 7278.
[17] Wu, J.; Li, W.; Chen, L.; Chu, S.; Zhao, C. Chin. J. Org. Chem. 2012, 32, 2141 (in Chinese).
(吴建章, 李物兰, 陈玲姿, 楚生辉, 赵承光, 卫涛, 杨树林, 李校堃, 有机化学, 2012, 32, 2141.)
[18] Liang, G.; Yang, S. L.; Shao, L. L.; Zhao, C. G.; Xiao, J.; Lv, Y. X.; Yang, J.; Zhao, Y.; Li, X. K. J. Asian. Nat. Prod. Res. 2008, 10, 957.
[19] Liang, G.; Yang, S.; Zhou, H.; Shao, L.; Huang, K.; Xiao, J.; Huang, Z.; Li, X. Eur. J. Med. Chem. 2009, 44, 915.
[20] Katritzky, A. R.; Girgis, A. S.; Slavov, S.; Tala, S. R.; Stoyanova-Slavova, I. Eur. J. Med. Chem. 2010, 45, 5185.
[21] Wu, J.; Zhang, Y.; Cai, Y.; Wang, J.; Weng, B.; Tang, Q.; Chen, X.; Pan, Z.; Liang, G.; Yang, S. Bioorg. Med. Chem. 2013, 21, 3058.
Options
Outlines

/

〈 〉